Eastwood Bio-Medical Canada Inc. (TSXV:EBM)

TSXV:EBM Revenue

Eastwood Bio-Medical Canada had revenue of 144.98K CAD in the quarter ending April 30, 2026, with 88.82% growth. This brings the company's revenue in the last twelve months to 787.78K, up 19.84% year-over-year. In the fiscal year ending October 31, 2025, Eastwood Bio-Medical Canada had annual revenue of 782.08K with 11.40% growth.

• Revenue (ttm): 787.78K
• Revenue Growth: +19.84%
• P/S Ratio: 83.07
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 65.44M

Revenue Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Oct 31, 2025	782.08K	80.00K	11.40%
Oct 31, 2024	702.08K	-165.86K	-19.11%
Oct 31, 2023	867.94K	-431.83K	-33.22%
Oct 31, 2022	1.30M	318.71K	32.49%
Oct 31, 2021	981.05K	262.72K	36.57%

Data Source: S&P Global Market Intelligence Last updated: Apr 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 11, 2026

Data Sources Report a data error